手辅助后腹腔镜与开放手术活体供肾切取术比较

Comparison of hand-assisted retroperitoneoscopic and open live donor nephrectomy

  • 摘要: 目的 比较手辅助后腹腔镜活体供肾切取术(hand-assisted retroperitoneoscopic live donor nephrectomy,HRPLDN)与开放活体供肾切取术(open live donor nephrectomy,ODN)的临床效果。 方法 回顾性分析解放军第309医院2009年3月-2014年3月110例活体亲属供肾者及受者的临床资料,HRPLDN组65例,ODN组45例。 结果 与ODN组比较,HRPLDN组供者失血量更少(85±41) ml vs (205±53) ml,P< 0.05,热缺血时间更长(121.5±48.2) s vs (93.4±47.3) s,P< 0.05,住院时间更短(7.3±1.5) d vs (10.6±2.3) d,P< 0.05。两组手术时间及术后1周血肌酐水平差异无统计学意义。并发症:HRPLDN组1例淋巴瘘,1例供肾包膜下血肿,1例腰静脉损伤出血;ODN组1例下腔静脉出血,2例切口脂肪液化。受者恢复情况比较:术后2周血肌酐和估算肾小球滤过率均无明显差异,肾功能恢复良好。HRPLDN和ODN组移植肾功能延迟恢复(delayed graft function,DGF)发生率分别为7.6%和8.8%,急性排斥反应(acute rejection,AR)发生率为4.6%和4.4%,尿瘘(urinary leakage,UL)发生率为1.5%和4.4%,差异均无统计学意义。110例供者及受者随访5 ~ 21个月,未出现肾功能异常。 结论 手辅助后腹腔镜活体供肾切取术相较开放手术,失血量明显减少,术后恢复快,住院时间更短,移植供受者DGF和尿瘘等并发症未明显增加,具有很好的安全性,可替代开放活体供肾切取术。

     

    Abstract: Objective To compare the clinical results of hand-assisted retroperitoneoscopic live donor nephrectomy (HRPLDN) and open 1ive donor nephrectomy (ODN). Methods Clinical data about 110 patients (HRPLDN in 65 cases and ODN in 45 cases) who underwent live donor nephrectomy in the 309th Hospital of Chinese PLA from March 2009 to March 2014 were retrospectively analyzed. Results Compared to ODN, HRPLDN donors had less estimated blood loss (85±41) ml vs (205±53) ml (P< 0.05), longer warm ischaemia time (121.5±48.2) s vs (93.4±47.3) s (P< 0.05) and shorter length of stay (7.3±1.5) d vs (10.6±2.3) d (P< 0.05). Complications were found in 6 cases, including lymphatic leakage, hematoma of renal subcapsule, lumbar vein injury in 3 patients respectively in HRPLDN group, inferior vena cava injury in 1 patient, incision fat liquefaction in 2 patients in ODN group. The recipients of two groups had similar serum creatinine and eGFR levels after two weeks. The incidence of delayed graft function (DGF), acute rejection (AR), urinary leakage (UL) in HRPLDN and ODN recipients were 7.6% (5/65) and 8.8% (4/45), 4.6% (3/65) and 4.4% (2/45), 1.5% (1/65) and 4.4% (2/45), respectively, which showed no significant differences (P> 0.05). All the 110 donors and recipients were followed up for 5-21 months, and their serum creatinine levels were normal. Conclusion Compared to ODN, HRPLDN shows superior results in terms of shorter length of stay and less estimated blood loss without increasing complications of donors and recipients. HRPLDN is as safe and reliable as ODN for living relative donors, which can replace open live donor nephrectomy.

     

/

返回文章
返回